Bioter S.A. (BIOT.AT)

Bioter S.A. (BIOT.AT) — VMCI valuation read

Headline read on BIOT.AT: VMCI of 41/100 versus a Industrials sector median of 50. The 9-point below-median position is what makes Bioter S.A. a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on BIOT.AT: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on BIOT.AT: value (BIOT.AT trades at 27.0x earnings, 50% above the Industrials median of 18.0x), quality (ROIC of 15.0% sits 5.0pp above the Industrials median (10.0%)), and risk (net debt to EBITDA of 1.6x is the rate-sensitivity line to watch). The value read also implies an EV/EBITDA gap of +4.0x against the Industrials 12.0x baseline.

BIOT.AT fell 2.4% over the trailing 7 days, with a -9.3% read on a 30-day basis.